at this point , the cancer specific survival rates were 77 % for patients in stage a , 59 % in stage b , 37 % in stage c , and 9 % for patients with tumors invading adjacent organs ( d1 ) , while no patient with macroscopic metastases to distant organs ( stage d2 ) survived beyond four and a half years ( median , 11 months ) .
C0006826
cancer
C0027651
tumors